From the Editor-in-Chief
Why do some people develop cancer while others do not?
by By William G. Nelson, MD, PhD
Executive Editor Kevin McLaughlin highlights stories from the Summer 2015 issue of 'Cancer Today.'
by By Kevin McLaughlin
There Goes the Neighborhood | Cost of Breast Cancer Treatment Affects Adherence | Cancer Treatment Can Reactivate Hepatitis B | First Biosimilar Drug Approved in U.S. | A Clearer Picture of Prostate Cancer | Summing Up Sunscreen
Your Cancer Guide
Create a list of guiding principles that allow you to shake off the small stuff.
by Hester Hill Schnipper
Caregiving With Confidence
You can't fix cancer, but you can make a difference.
by Marc Silver
Ductal carcinoma in situ is the fourth most common cancer diagnosis in women. Some say it's not "really" cancer. But you wouldn't know that based on how it is treated.
by Sue Rochman
Since P.J. Lukac's glioblastoma diagnosis, the young pediatrician has worked hard to spread awareness and understanding of the disease.
by Stephen Ornes
Yesterday & Today
Ventriloquist Shari Lewis and her sidekick, a white wool puppet named Lamb Chop, won the hearts of generations of children who tuned in to her television shows.
by Jocelyn Selim
Expensive treatments can leave patients with a mountain of debt. Resources are available to help.
by Bara Vaida
Young adults undergoing cancer treatment who may want to have children should talk with their doctors about ways to preserve their fertility.
by Marci A. Landsmann
Reaping the Benefits | Sleep Solution?
Researcher David J. Hauser discusses how war metaphors may make people less likely to engage in preventive behaviors.
by Sharlene George
Moving beyond active cancer treatment, dealing with cancer-related anger, and managing the effects of neuropathy
Cancer survivor starts organization that hosts free group fitness events for survivors, patients and caregivers.
by Rebecca Hanlon
Beverly McKee, Charlie Haygood, Patricia Fernandes.
A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.
by Kate Yandell
Survivors and advocates display their posters alongside the work of thousands of cancer researchers.
by Kevin McLaughlin
Drug developers behind the six currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.
A pair of studies demonstrated encouraging clinical outcomes with two different CAR T-cell therapies for patients with advanced solid tumors.
The U.S. Food and Drug Administration has for the first time approved an immunotherapeutic for breast cancer.
Researchers are studying how to treat EGFR-positive non-small cell lung cancer that has become resistant to tyrosine kinase inhibitors.
A Lesson in Service
donate to the AACR